JGP Wealth Management’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$3.66M Buy
46,750
+798
+2% +$64.4K 0.33% 57
2026
Q1
$3.98M Sell
45,952
-28,556
-38% -$2.74M 0.41% 49
2025
Q4
$7.16M Buy
74,508
+498
+0.7% +$48.4K 0.75% 37
2025
Q3
$7.07M Buy
74,010
+2,643
+4% +$243K 0.78% 38
2025
Q2
$6.22M Buy
71,367
+847
+1% +$71.8K 0.75% 40
2025
Q1
$6.34M Sell
70,520
-77
-0.1% -$6.89K 0.83% 39
2024
Q4
$5.64M Sell
70,597
-11,604
-14% -$1M 0.73% 42
2024
Q3
$7.4M Buy
82,201
+2,819
+4% +$237K 0.95% 42
2024
Q2
$6.25M Sell
79,382
-492
-0.6% -$40.3K 0.89% 42
2024
Q1
$6.96M Buy
79,874
+1,221
+2% +$104K 1.01% 44
2023
Q4
$6.48M Buy
78,653
+3,567
+5% +$272K 0.96% 40
2023
Q3
$5.88M Buy
75,086
+1,874
+3% +$157K 0.99% 41
2023
Q2
$6.45M Buy
73,212
+4,656
+7% +$401K 1.05% 39
2023
Q1
$5.53M Buy
68,556
+6,606
+11% +$538K 0.97% 40
2022
Q4
$4.81M Sell
61,950
-22,698
-27% -$1.84M 0.88% 42
2022
Q3
$6.98M Buy
84,648
+3,822
+5% +$343K 1.47% 30
2022
Q2
$7.24M Buy
80,826
+3,803
+5% +$385K 1.46% 29
2022
Q1
$8.66M Buy
77,023
+4,545
+6% +$480K 1.6% 26
2021
Q4
$7.68M Buy
72,478
+4,853
+7% +$562K 1.43% 28
2021
Q3
$8.48M Buy
67,625
+1,151
+2% +$149K 1.83% 21
2021
Q2
$8.25M Buy
66,474
+4,345
+7% +$546K 1.77% 23
2021
Q1
$7.34M Buy
62,129
+1,314
+2% +$154K 1.64% 16
2020
Q4
$7.12M Buy
60,815
+4,388
+8% +$483K 1.65% 16
2020
Q3
$5.96M Buy
56,427
+3,431
+6% +$345K 1.58% 19
2020
Q2
$4.86M Buy
52,996
+5,968
+13% +$572K 1.43% 25
2020
Q1
$4.67M Sell
47,028
-644
-1% -$68.5K 1.65% 20
2019
Q4
$5.48M Buy
47,672
+4,994
+12% +$548K 1.62% 21
2019
Q3
$4.52M Buy
42,678
+757
+2% +$79K 1.57% 22
2019
Q2
$4.08M Buy
41,921
+1,232
+3% +$112K 1.45% 26
2019
Q1
$3.71M Buy
40,689
+1,382
+4% +$124K 1.4% 31
2018
Q4
$3.58M Buy
39,307
+764
+2% +$71.4K 1.48% 21
2018
Q3
$3.79M Buy
38,543
+327
+0.9% +$30.2K 1.52% 19
2018
Q2
$3.27M Buy
+38,216
New +$3.19M 1.37% 26

Other funds holding MDT

JGP Wealth Management's MDT Position: Q2 2026 in Review

JGP Wealth Management increased its Medtronic (MDT) stake by 1.7% in Q2 2026, buying an estimated $64.4K and bringing the position to 46,750 shares worth $3.66M. The position accounts for 0.33% of the portfolio, ranked #57.

JGP Wealth Management first reported a position in MDT in Q2 2018 and has held it in 33 quarters since. The position peaked at $8.66M in Q1 2022. 729 funds tracked by Wall St. Rank hold MDT as of Q2 2026.

  • JGP Wealth Management held 46,750 shares of Medtronic worth $3.66M as of Q2 2026.
  • JGP Wealth Management bought 798 Medtronic shares in Q2 2026, an estimated $64.4K.
  • Medtronic made up 0.33% of JGP Wealth Management's portfolio in Q2 2026, its #57 holding.
  • JGP Wealth Management first reported a position in Medtronic in Q2 2018 and has held it in 33 quarters since.
  • JGP Wealth Management's Medtronic position peaked at $8.66M in Q1 2022.
  • 729 funds tracked by Wall St. Rank held Medtronic as of Q2 2026.

Based on JGP Wealth Management's 13F filing for Q2 2026, filed 7 Jul 2026.